LDLR and familial hyperaldosteronism: The subjects with FH generally have a mutation in one of the following genes: the low-density lipoprotein receptor gene (LDLR—the most common), the apolipoprotein B gene (APOB3500), and a gain-of-function type of mutation of the proprotein convertase subtilisin kexin 9 gene (PCSK9).